Compound information
- Natural Products
- ZC336800
- Molecular Formula
- C10H12Cl2N2O3S
- Molecular Weight
- 309.994568604 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[4-chloro-3-(dimethylsulfamoyl)phenyl]acetamide
- InChI
- InChI=1S/C10H12Cl2N2O3S/c1-14(2)18(16,17)9-5-7(3-4-8(9)12)13-10(15)6-11/h3-5H,6H2,1-2H3,(H,13,15)
- InChI Key
- YEHYODCKTNLFQU-UHFFFAOYSA-N
- SMILES
- CN(C)S(=O)(=O)c1cc(NC(=O)CCl)ccc1Cl
- Source
- ZINC000003885310
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 1.609 |
LogS | -3.147 | LogD | 2.084 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.112 | Pgp substrate | 0.033 |
HIA | 0.957 | F20 % | 0.987 |
F30 % | 0.956 | Caco-2 | -5.355 |
MDCK | -5.433 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.265 | PPB | 98.656 |
VD | 1.14 | Fu | 0.882 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.976 | CYP1A2 substrate | 0.721 |
CYP2A6 substrate | 0.804 | CYP2B6 substrate | 0.689 |
CYP2C19 inhibitor | 0.804 | CYP2C19 substrate | 0.88 |
CYP2C8 substrate | 0.85 | CYP2C9 inhibitor | 0.489 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.122 |
CYP2D6 substrate | 0.939 | CYP2E1 substrate | 0.896 |
CYP3A4 inhibitor | 0.643 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.311 | CL | 11.443 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.117 | Hepatotoxicity | 0.983 |
Mutagenicity | 0.014 | Rat Oral Acute Toxicity | 0.276 |
FDAMDD | 0.174 | Skin Sensitization | 0.983 |
Carcinogenicity | 0.24 | Eye Corrosion | 0.484 |
Eye Irritation | 0.047 | Respiratory Toxicity | 0.984 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.475 | IGC50 | 4.464 |
LC50FM | 4.403 | LC50DM | 4.37 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.1 | NR-AR-LBD | 0.426 |
NR-AhR | 0.763 | NR-Aromatase | 0.852 |
NR-ER | 0.349 | NR-ER-LBD | 0.582 |
NR-PPAR-gamma | 0.92 | SR-ARE | 0.98 |
SR-ATAD5 | 0.621 | SR-HSE | 0.914 |
SR-MMP | 0.497 | SR-p53 | 0.896 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.